Non Small Cell Lung Cancer, Oligometastatic
1 clinical trials · Condition
◉ Watch Non Small Cell Lung Cancer, Oligometastatic
| Record | Firm | Date |
|---|---|---|
| The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment (NCT01796288) | Wu Jieping Medical Foundation | 2012-10-01 |
Track Non Small Cell Lung Cancer, Oligometastatic automatically
Every clearance here is in the API, with alerts when new ones post.